Literature DB >> 33099459

The Swiss Prison Study (SWIPS): Protocol for Establishing a Public Health Registry of Prisoners in Switzerland.

Thomas Gaisl1,2,3, Naser Musli2, Patrick Baumgartner3, Marc Meier2, Silvana K Rampini2, Eva Blozik4, Edouard Battegay2, Malcolm Kohler3, Shekhar Saxena1.   

Abstract

BACKGROUND: The health aspects, disease frequencies, and specific health interests of prisoners and refugees are poorly understood. Importantly, access to the health care system is limited for this vulnerable population. There has been no systematic investigation to understand the health issues of inmates in Switzerland. Furthermore, little is known on how recent migration flows in Europe may have affected the health conditions of inmates.
OBJECTIVE: The Swiss Prison Study (SWIPS) is a large-scale observational study with the aim of establishing a public health registry in northern-central Switzerland. The primary objective is to establish a central database to assess disease prevalence (ie, International Classification of Diseases-10 codes [German modification]) among prisoners. The secondary objectives include the following: (1) to compare the 2015 versus 2020 disease prevalence among inmates against a representative sample from the local resident population, (2) to assess longitudinal changes in disease prevalence from 2015 to 2020 by using cross-sectional medical records from all inmates at the Police Prison Zurich, Switzerland, and (3) to identify unrecognized health problems to prepare successful public health strategies.
METHODS: Demographic and health-related data such as age, sex, country of origin, duration of imprisonment, medication (including the drug name, brand, dosage, and release), and medical history (including the International Classification of Diseases-10 codes [German modification] for all diagnoses and external results that are part of the medical history in the prison) have been deposited in a central register over a span of 5 years (January 2015 to August 2020). The final cohort is expected to comprise approximately 50,000 to 60,000 prisoners from the Police Prison Zurich, Switzerland.
RESULTS: This study was approved on August 5, 2019 by the ethical committee of the Canton of Zurich with the registration code KEK-ZH No. 2019-01055 and funded in August 2020 by the "Walter and Gertrud Siegenthaler" foundation and the "Theodor and Ida Herzog-Egli" foundation. This study is registered with the International Standard Randomized Controlled Trial Number registry. Data collection started in August 2019 and results are expected to be published in 2021. Findings will be disseminated through scientific papers as well as presentations and public events.
CONCLUSIONS: This study will construct a valuable database of information regarding the health of inmates and refugees in Swiss prisons and will act as groundwork for future interventions in this vulnerable population. TRIAL REGISTRATION: ISRCTN registry ISRCTN11714665; http://www.isrctn.com/ISRCTN11714665. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/23973. ©Thomas Gaisl, Naser Musli, Patrick Baumgartner, Marc Meier, Silvana K Rampini, Eva Blozik, Edouard Battegay, Malcolm Kohler, Shekhar Saxena. Originally published in JMIR Research Protocols (http://www.researchprotocols.org), 08.12.2020.

Entities:  

Keywords:  epidemiology; health register; prison medicine; public health

Year:  2020        PMID: 33099459      PMCID: PMC7755536          DOI: 10.2196/23973

Source DB:  PubMed          Journal:  JMIR Res Protoc        ISSN: 1929-0748


  9 in total

1.  Is there a recreational misuse potential for pregabalin? Analysis of anecdotal online reports in comparison with related gabapentin and clonazepam data.

Authors:  Fabrizio Schifano; Stefano D'Offizi; Michele Piccione; Ornella Corazza; Paolo Deluca; Zoe Davey; Giuditta Di Melchiorre; Lucia Di Furia; Magí Farré; Liv Flesland; Miia Mannonen; Aino Majava; Stefania Pagani; Teuvo Peltoniemi; Holger Siemann; Arvid Skutle; Marta Torrens; Cinzia Pezzolesi; Peer van der Kreeft; Norbert Scherbaum
Journal:  Psychother Psychosom       Date:  2011-01-04       Impact factor: 17.659

2.  Underestimated impact of novel psychoactive substances: laboratory confirmation of recreational drug toxicity in Oslo, Norway.

Authors:  Odd Martin Vallersnes; Per Sverre Persett; Elisabeth Leere Øiestad; Ritva Karinen; Fridtjof Heyerdahl; Knut Erik Hovda
Journal:  Clin Toxicol (Phila)       Date:  2017-04-13       Impact factor: 4.467

Review 3.  The health of prisoners.

Authors:  Seena Fazel; Jacques Baillargeon
Journal:  Lancet       Date:  2010-11-18       Impact factor: 79.321

4.  Chronic health conditions reported by male inmates newly admitted to Canadian federal penitentiaries.

Authors:  Lynn A Stewart; Amanda Nolan; Jeremy Sapers; Jenelle Power; Linda Panaro; Jonathan Smith
Journal:  CMAJ Open       Date:  2015-01-13

5.  Inclusion health: addressing the causes of the causes.

Authors:  Michael Marmot
Journal:  Lancet       Date:  2017-11-12       Impact factor: 79.321

6.  Use of psychoactive substances in prison: Results of a study in the Lyon-Corbas prison, France.

Authors:  F Sahajian; A Berger-Vergiat; E Pot
Journal:  Rev Epidemiol Sante Publique       Date:  2017-09-06       Impact factor: 1.019

7.  Approved and Off-Label Use of Prescribed Psychotropic Medications among Federal Canadian Inmates.

Authors:  Gregory P Brown; Lynn A Stewart; Terry Rabinowitz; Harold Boudreau; Angela J Wright
Journal:  Can J Psychiatry       Date:  2018-04-29       Impact factor: 4.356

8.  Commentary: The opioid overdose epidemic: Evidence-based interventions.

Authors:  Peter Barglow
Journal:  Am J Addict       Date:  2018-10-12

9.  Concordance between medical records and interview data in correctional facilities.

Authors:  Jennifer R Bai; Dhritiman V Mukherjee; Montina Befus; Zoltan Apa; Franklin D Lowy; Elaine L Larson
Journal:  BMC Med Res Methodol       Date:  2014-04-09       Impact factor: 4.615

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.